Saturday, September 07, 2019 9:12:33 AM
I took a huge risk on NWBO when I started buying at .16-.18 a share back in 2017. The alphapuppy had been speaking highly of this technology back in 2014-2016 when they were trading at $7-$10 a share. I had some unfortunate events in my life that precluded me buying then. I started my NWBO investment in July 2017.
Bigger jumped in right after I did.
My buying was highly speculative and the company was on the brink of financial failure. But I continue to believe in the technology and their data. I’ve added along the way and watched it jump to .35-.40 and back to .20 a few times. It’s been quite the ride.
I think we’re close to the end of this roller coaster, but I’ve said that before. I’ve never felt more confident. I’d love to see a buyout at $15 or more. The only thing I’d love more is if this platform starts us on a road to cure for patients. I’ve seen more death and despair than I’ve cared to in my career. A career in cancer care takes its toll and I have some memories of young people battling that I can’t forget. I want nothing more than to give hope to humans suffering from cancer. I have my money where my mouth is. If this vaccine puts hope into GBM, it can put hope anywhere.
I’m so looking forward to topline data. I want DCVAX to validate the work of Dr. Liau and Dr. Bosch and validate the risk that LP and patient investors have taken to get across the finish line. I sense that we’ll get some answers on the science and on the market in the next 60 days. If there truly is a significant naked short position, it would be heavily exposed by some positive data announcements.
I normally enjoy fireworks in July, but we can have some for Halloween this year.
Bigger jumped in right after I did.
My buying was highly speculative and the company was on the brink of financial failure. But I continue to believe in the technology and their data. I’ve added along the way and watched it jump to .35-.40 and back to .20 a few times. It’s been quite the ride.
I think we’re close to the end of this roller coaster, but I’ve said that before. I’ve never felt more confident. I’d love to see a buyout at $15 or more. The only thing I’d love more is if this platform starts us on a road to cure for patients. I’ve seen more death and despair than I’ve cared to in my career. A career in cancer care takes its toll and I have some memories of young people battling that I can’t forget. I want nothing more than to give hope to humans suffering from cancer. I have my money where my mouth is. If this vaccine puts hope into GBM, it can put hope anywhere.
I’m so looking forward to topline data. I want DCVAX to validate the work of Dr. Liau and Dr. Bosch and validate the risk that LP and patient investors have taken to get across the finish line. I sense that we’ll get some answers on the science and on the market in the next 60 days. If there truly is a significant naked short position, it would be heavily exposed by some positive data announcements.
I normally enjoy fireworks in July, but we can have some for Halloween this year.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
